Patents Assigned to RESPIVANT SCIENCES GMBH
  • Methods of treating respiratory syncytial virus infections
    Patent number: 10835512
    Abstract: Compositions and methods for the treatment of respiratory syncytial virus infections are provided.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: November 17, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Manfred Keller, Ahmet Tutuncu
  • Cromolyn Compositions for Treatment of Chronic Cough Due to Idiopathic Pulmonary Fibrosis
    Publication number: 20200155452
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Application
    Filed: September 19, 2019
    Publication date: May 21, 2020
    Applicant: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu
  • Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
    Patent number: 10596146
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: March 24, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Robert Craig Armstrong
  • Cromolyn compositions for treatment of pulmonary fibrosis
    Patent number: 10583113
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 10, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu, Robert Craig Armstrong
  • Cromolyn compositions for treatment of pulmonary fibrosis
    Patent number: 10561635
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: February 18, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu, Robert Craig Armstrong
  • Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
    Patent number: 10463613
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: November 5, 2019
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu
  • Methods for the treatment of mast cell related disorders with mast cell stabilizers
    Patent number: 10391078
    Abstract: Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: August 27, 2019
    Assignee: Respivant Sciences GmbH
    Inventors: William Gerhart, Pravin Soni, Ahmet Tutuncu
  • Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
    Patent number: 10265296
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: April 23, 2019
    Assignee: RESPIVANT SCIENCES GMBH
    Inventors: William Gerhart, Pravin Soni, Robert Craig Armstrong
  • Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
    Patent number: 10265267
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: April 23, 2019
    Assignee: RESPIVANT SCIENCES GMBH
    Inventors: William Gerhart, Ahmet Tutuncu, Pravin Soni
  • Mast cell stabilizers treatment for systemic disorders
    Patent number: 10238628
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: March 26, 2019
    Assignee: RESPIVANT SCIENCES GMBH
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Methods for the treatment of mast cell related disorders with mast cell stabilizers
    Patent number: 10238625
    Abstract: Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: March 26, 2019
    Assignee: RESPIVANT SCIENCES GMBH
    Inventors: William Gerhart, Pravin Soni, Ahmet Tutuncu